Clinical Trial Update: WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for WSD0922-FU evaluating safety and preliminary activity in glioblastoma, anaplastic astrocytoma, and non-small cell lung cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Brain Metastases
• Glioblastoma
• Non-small Cell Lung Cancer

Drugs mentioned

• WSD0922-FU (WSD0922-FU)

Snippet

Sponsor: Mayo Clinic | Conditions: Anaplastic Astrocytoma, IDH-Wildtype, Glioblastoma, IDH-Wildtype | Phase 1 | Status: ACTIVE_NOT_RECRUITING